Jaguar Health, Pipeline Review and Progress

In this article:

NEW YORK, NY / ACCESSWIRE / April 1, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Jaguar Health, Inc. (JAGX), is a commercial stage natural-products pharmaceuticals company that focuses on developing gastrointestinal products for human prescription use and animals worldwide.

Mytesi® (crofelemer), is a product of Jaguar's wholly-owned subsidiary Napo Pharmaceuticals, is approved by the FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Jaguar health, pipeline review and progress in this full research report READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/jaguar-health-2/

Crofelemer, the active ingredient in Mytesi®, is a botanical (plant-based) drug extracted and purified from the red bark sap of the medicinal Croton lechleri tree in the Amazon rainforest. Napo has established a sustainable harvesting program for crofelemer to ensure a high degree of quality and ecological integrity.

Sales of Mytesi® are growing but what level revenues are needed to profit READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/jaguar-health-2/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: editor@tradersnewssource.com

SOURCE: Traders News Source



View source version on accesswire.com:
https://www.accesswire.com/540633/Jaguar-Health-Pipeline-Review-and-Progress

Advertisement